Gilead Sciences (GILD) Non-Current Debt (2010 - 2026)

Gilead Sciences (GILD) has 17 years of Non-Current Debt data on file, last reported at $20.9 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 5.8% year-over-year to $20.9 billion; the trailing twelve-month figure through Mar 2026 stood at $20.9 billion (down 5.8% YoY), and the FY2025 full-year result was $22.1 billion, down 11.11% from the prior year.
• Non-Current Debt for Q1 2026 stood at $20.9 billion, down from $22.1 billion in the prior quarter.
• Across five years, Non-Current Debt topped out at $25.2 billion in Q2 2022 and bottomed at $20.9 billion in Q1 2026.
• The 5-year median for Non-Current Debt is $22.1 billion (2025), against an average of $22.7 billion.
• The widest annual swing landed in 2023, when Non-Current Debt retreated 15.82%; it then advanced 7.36% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $23.0 billion in 2022, then grew by 1.01% to $23.2 billion in 2023, then advanced by 7.36% to $24.9 billion in 2024, then slipped by 11.11% to $22.1 billion in 2025, then decreased by 5.73% to $20.9 billion in 2026.
• The last three Non-Current Debt figures came in at $20.9 billion (Q1 2026), $22.1 billion (Q4 2025), and $22.1 billion (Q3 2025), per Business Quant data.

Peer Comparison